Search or choose
Find the right test or package.
The IgVH mutation status is an important part of CLL diagnosis and prognosis. It can help healthcare providers make treatment decisions and predict the likely course of the disease. Patients with mutated IgVH CLL typically have a slower disease progression and...
The IgVH mutation status is an important part of CLL diagnosis and prognosis. It can help healthcare providers make treatment decisions and predict the likely course of the disease. Patients with mutated IgVH CLL typically have a slower disease progr...
The IgVH mutation status is an important part of CLL diagnosis and prognosis. It can help healthcare providers make treatment decisions and predict the likely course of the disease. Patients with mutated IgVH CLL typically have a slower disease progression and may not require treatment right away, whereas those with unmutated IgVH CLL may require more aggressive treatment sooner.
The IgVH mutation status is an important part of CLL diagnosis and prognosis. It can help healthcare providers make treatment decisions and predict the likely course of the disease. Patients with mutated IgVH CLL typically have a slower disease progression and may not require treatment right away, whereas those with unmutated IgVH CLL may require more aggressive treatment sooner.
Find the right test or package.
Pick a convenient time.
A trained expert arrives home.
Samples move through the lab process.
Reports are delivered online.